DESIRAE WELBY: Open Payments
NPI 1851728216 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 53 payments from 14 companies in 2025. Trend: 2023 $1,004 · 2024 $2,035 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 7 | $219 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $177 |
| ABC Home Medical Supply, Inc. | 9 | $160 |
| Sumitomo Pharma America, Inc. | 6 | $130 |
| ABBVIE INC. | 6 | $99 |
| UROGEN PHARMA, INC. | 3 | $78 |
| Endo USA, Inc. | 3 | $71 |
| Janssen Biotech, Inc. | 3 | $70 |
| Antares Pharma, Inc. | 4 | $68 |
| Myriad Genetic Laboratories, Inc. | 3 | $66 |
Products named: ADSTILADRIN, PYLARIFY, ORGOVYX, XIAFLEX, ERLEADA, XYOSTED, PROLARIS, GEMTESA.
Industry payments across MO — which companies pay providers there.
